University Hospital of Wales
14
2
3
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
7.1%
1 terminated/withdrawn out of 14 trials
85.7%
-0.8% vs industry average
7%
1 trials in Phase 3/4
17%
1 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
Sedation, Temperature and Pressure After Cardiac Arrest and Resuscitation
Role: collaborator
Prospective Evaluation Of Exercise-Induced Cardiac Conduction Instability In Predicting Ventricular Fibrillation Events In Hypertrophic Cardiomyopathy
Role: collaborator
Observational Study of the LMA Protector
Role: collaborator
DAISy-PCOS Phenome Study - Dissecting Androgen Excess and Metabolic Dysfunction in Polycystic Ovary Syndrome
Role: collaborator
Alpha 2 Agonists for Sedation to Produce Better Outcomes From Critical Illness (A2B Trial)
Role: collaborator
Head Computed Tomography for Predicting Neurological Outcome After Cardiac Arrest
Role: collaborator
LOng COvid Multidisciplinary Consortium: Optimising Treatments and servIces Across the NHS (LOCOMOTION)
Role: collaborator
Manuka Honey Sinus Rinse Study
Role: collaborator
UHW Angiogram Video Project
Role: lead
COVID-19 Risk From Attending Outpatient Radiology Appointments
Role: collaborator
Neonatal Complications of Coronavirus Disease (COVID-19)
Role: collaborator
Quantitative Stress Echocardiography to Diagnose Myocardial Ischaemia
Role: lead
Beta Testing of a New Assessment in Huntington's Disease (HD)
Role: collaborator
Cognitive Impairment Following Cardiac Arrest and Target Temperature Management
Role: collaborator
All 14 trials loaded